ID: ALA4776169

Max Phase: Preclinical

Molecular Formula: C39H61N5O6S

Molecular Weight: 728.01

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCO[C@H](C[C@H](C(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H]1CCCCN1C)C(CC)CC)c1nc(C(=O)N[C@@H](Cc2ccccc2)C[C@H](C)C(=O)O)cs1

Standard InChI:  InChI=1S/C39H61N5O6S/c1-9-28(10-2)34(42-36(46)31-19-15-16-20-43(31)7)38(47)44(8)32(25(4)5)23-33(50-11-3)37-41-30(24-51-37)35(45)40-29(21-26(6)39(48)49)22-27-17-13-12-14-18-27/h12-14,17-18,24-26,28-29,31-34H,9-11,15-16,19-23H2,1-8H3,(H,40,45)(H,42,46)(H,48,49)/t26-,29+,31+,32+,33+,34-/m0/s1

Standard InChI Key:  CXFITKDJXPWWPG-PUNIVKTQSA-N

Associated Targets(Human)

L-540 (108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DEL (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 728.01Molecular Weight (Monoisotopic): 727.4343AlogP: 5.95#Rotatable Bonds: 20
Polar Surface Area: 141.17Molecular Species: ACIDHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.21CX Basic pKa: 7.09CX LogP: 3.40CX LogD: 3.04
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.15Np Likeness Score: -0.06

References

1. Courter JR,Hamilton JZ,Hendrick NR,Zaval M,Waight AB,Lyon RP,Senter PD,Jeffrey SC,Burke PJ.  (2020)  Structure-activity relationships of tubulysin analogues.,  30  (14): [PMID:32527543] [10.1016/j.bmcl.2020.127241]

Source